PARIS, Jan. 4 /CNW/ - The inaugural meeting of the Mongolian National
Immunization Technical Advisory Group (NITAG) was held at the Ministry
of Health in Ulaanbaatar on December 6, 2010.
The NITAG is the first of its kind in Mongolia and was established based
on recommendations from the World Health Organization (WHO). The
committee's role is to advise the Ministry of Health on all issues
related to immunization and vaccines such as the choice of vaccines to
introduce, vaccine schedules, quality and safety, and delivery systems.
The NITAG was approved by a ministerial decree issued in August 2010
defining terms of reference and procedural guidelines.
The Supporting Independent Immunization and Vaccine Advisory Committees
(SIVAC) Initiative, implemented by the Agence de Medecine Preventive
(AMP) in partnership with the International Vaccine Institute (IVI),
played an important role in the creation of the NITAG. SIVAC, along
with WHO and the WHO Western Pacific Regional Office (WPRO), provided
technical support to the Mongolian Ministry of Health in establishing
committee structure, roles, and responsibilities.
The first meeting of the Mongolian NITAG aimed to revise technical
guidelines and to clarify membership issues. The meeting was chaired by
the Vice Minister of Health, Dr. Jadamba Tsolmon, and brought together
10 newly elected NITAG members. Among other things, it was decided that
the National Center for Communicable Diseases will serve as the
secretariat and that the committee will consist of 11 core (voting)
members and 9 non-voting members. Members also agreed to hold four
meetings in 2011 and to develop a detailed work plan.
"This NITAG is a very important step towards country ownership of
important health issues," said Dr. Philippe Stoeckel, chairman of AMP.
"It will enable health authorities to formulate immunization policies
and strategies according to Mongolia's specific needs. We hope it will
lead to the creation of similar committees in other countries."
The Mongolian NITAG is the second to be established with support from
the SIVAC Initiative. The first was launched in Cote d'Ivoire in
SOURCE Agence de Medecine Preventive (AMP)
For further information: